LONG DANIEL D. (SVP, Drug Discovery) sold 3.3% of their position (3.33K shares) of SEPTERNA, INC. on the open market
Open‑market sale worth $126.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0001193125-26-382267
Officer· SVP, Drug Discovery
Since Feb 2026
-3.33K
Net shares
Net seller
$126.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 6.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.33K
Price / share
$2.76
Trade value
$9.20K
% of position
3.5%
9/1/2026
96.41K→99.75K
Common Stock
Direct
Shares
−3.33K
Price / share
$37.83
Trade value
$126.08K
% of position
3.3%
9/1/2026
99.75K→96.41K
Total
Net shares
+0.00
Net value
-$116.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +3.33K | $2.76 | $9.20K | 3.5% | 96.41K | 99.75K |
| Common Stock Direct | 9/1/2026 | S · Sale | −3.33K | $37.83 | $126.08K | 3.3% | 99.75K | 96.41K |
| Total | +0.00 | -$116.88K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
2.76
Held after
9.09K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.33K shares | 9/1/2026 | M · Option Exercise | −3.33K | 2.76 | — | 9.09K |